Global Liquid Biopsy Market Analysis 2013-2016 - Forecast to 2022 By Disease Indication, Biomarker, Sample Type, Application & Key Companies

Dublin, March 03, 2017 -- Research and Markets has announced the addition of the "Global Liquid Biopsy Market Analysis 2016 - Forecast to 2022" report to their offering.

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

Scope of the Report

Disease Indication

• Breast Cancer
• Gastrointestinal Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Leukemia

Biomarker

• Exosomes
• Circulating Tumor DNA (ctDNA)
• Circulating Tumor Cells (CTC)
• Single Gene Analysis (PCR Microarrays)
• Multi - gene - parallel Analysis (NGS)

Sample Type

• Urine Sample based
• Blood Sample based
• Saliva
• Tissue fluids

Application

• Molecular Health Monitoring
• Therapy Selection for Metastatic Breast Cancer (MBS)
• Therapy Selection for Other Metastatic Cancer

Company Profiles

• Internap Corporation
• CDN Networks
• Tata Communications
• Level 3 Communications
• Google Inc.
• Limelight Networks, Inc.
• Highwinds Network Group, Inc.
• Akamai Technologies, Inc.
• Verizon Communications, Inc.
• Amazon Web Services, Inc.
• CloudFlare, Inc.
• Orange S.A.
• MaxCDN Enterprise
• Ericssion
• AT&T Inc.

For more information about this report visit http://www.researchandmarkets.com/research/wtw4hh/global_liquid

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: In Vitro Diagnostics